Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DOSIsoft is a French healthcare software company that develops imaging, dosimetry, treatment planning, and patient-specific quality assurance software for radiation oncology and nuclear medicine. The company originated in 2002 as a spin-off from Gustave Roussy and Institut Curie and focuses on improving cancer treatment quality, safety, and workflow efficiency. Its commercial portfolio includes the PLANET platform for voxel-based personalized dosimetry and theranostics workflows, as well as ThinkQA and related QA products for radiotherapy verification and in vivo dosimetry. DOSIsoft states that its software is used in more than 600 hospital centers across 60 countries, with products carrying CE marking and certain FDA clearances. The company operates from France with a U.S. branch in Miami and collaborates with hospitals, distributors, and industry partners such as Elekta.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DOSIsoft.